These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 37137851)

  • 1. [Meta-analysis of the clinical efficacy of live bifidobacterium bacteria preparation combined with entecavir in the treatment of hepatitis B virus-related cirrhosis].
    Chen H; Yuan HX; Li XH
    Zhonghua Gan Zang Bing Za Zhi; 2023 Mar; 31(3):258-264. PubMed ID: 37137851
    [No Abstract]   [Full Text] [Related]  

  • 2. The clinical efficacy and adverse effects of Entecavir plus Thymosin alpha-1 combination therapy versus Entecavir Monotherapy in HBV-related cirrhosis: a systematic review and meta-analysis.
    Peng D; Xing HY; Li C; Wang XF; Hou M; Li B; Chen JH
    BMC Gastroenterol; 2020 Oct; 20(1):348. PubMed ID: 33076834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of entecavir and lamivudine for hepatitis B decompensated cirrhosis: meta-analysis.
    Ye XG; Su QM
    World J Gastroenterol; 2013 Oct; 19(39):6665-78. PubMed ID: 24151397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Compound Biejia-Ruangan tablet as an adjunctive therapy to entecavir for chronic hepatitis B complicated with hepatic fibrosis: A systematic review and meta-analysis of randomized controlled trials.
    Xu YH; Xue C
    Medicine (Baltimore); 2022 Aug; 101(32):e30020. PubMed ID: 35960113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Meta-analysis of influences of Biejiajian Pill combined with entecavir on serum liver fibrosis markers of compensatory period of hepatitis b cirrhosis: Protocol of systematic review and meta-analysis.
    Zhang T; Yang Y; Wang B; Zheng X; Wang L; Feng X; Li G; Shi J; Cao N
    Medicine (Baltimore); 2019 Dec; 98(51):e18458. PubMed ID: 31861022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the efficacy of Biejia decoction pill combined with entecavir in the treatment of hepatitis B liver fibrosis/cirrhosis by VCTE.
    Wan L; Hu C; Wang F; Xu K; Li F; He B; Wu Z; Luo L; Wen Z
    Sci Rep; 2023 Nov; 13(1):19616. PubMed ID: 37949927
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Efficacy and safety of Entecavir monotherapy switched from Lamivudine combined Adefovir Dipivoxil for chronic hepatitis B virus-related compensated liver cirrhosis].
    Lai XJ; Lian JS; Chen JY; Zhang YM; Jia HY; Zheng L; Yang YD
    Zhonghua Gan Zang Bing Za Zhi; 2018 Feb; 26(2):113-118. PubMed ID: 29804377
    [No Abstract]   [Full Text] [Related]  

  • 8. [Efficacy Observation of Yiguanjian Decoction Combined Adefovir Dipivoxil Tablet in Treating HBeAg Negative Chronic Viral Hepatitis B Active Compensated Liver Cirrhosis Patients].
    Duan SH; Bao ZY; Yuan XD; Wang L; Liu MS
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2016 May; 36(5):535-8. PubMed ID: 27386642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of Fuzheng Huayu tablet on antiviral effect of entecavir in patients with hepatitis B cirrhosis.
    Cheng DY; Zhao ZM; Wan G; Zheng HW; Huang JQ; Liu CH; Xing HC
    Hepatobiliary Pancreat Dis Int; 2022 Oct; 21(5):479-484. PubMed ID: 35346577
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and virological response to entecavir in HBV-related chronic hepatitis or cirrhosis: data from the clinical practice in a single-centre cohort.
    Marengo A; Bitetto D; D'Avolio A; Ciancio A; Fabris C; Marietti M; Toniutto P; Di Perri G; Rizzetto M; Marzano A
    Antivir Ther; 2013; 18(1):87-94. PubMed ID: 22872649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The efficacy of Chinese patent medicine combined with entecavir for the treatment of chronic HBV-related liver fibrosis or cirrhosis: Protocol for a systematic review and meta-analysis of randomized controlled trials or prospective cohort studies.
    Song Y; Zhao J; Wang S; Huang H; Hong J; Zuo J; Huo S
    Medicine (Baltimore); 2019 May; 98(22):e15732. PubMed ID: 31145288
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The efficacy and safety comparison between tenofovir and entecavir in treatment of chronic hepatitis B and HBV related cirrhosis: A systematic review and Meta-analysis.
    Han Y; Zeng A; Liao H; Liu Y; Chen Y; Ding H
    Int Immunopharmacol; 2017 Jan; 42():168-175. PubMed ID: 27915131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of YinQiSanHuang-antiviral decoction in chronic hepatitis B: study protocol for a randomized, placebo-controlled, double-blinded trial.
    Wu QJ; Lv WL; Li JM; Zhang TT; Zhou WH; Zhang Q; Wang JC; Wang QN; Zhang RX; Zhao X; Chen ST; Liu S; Li GH; Cao ZM; Xu L; Chen J
    Trials; 2020 Jun; 21(1):482. PubMed ID: 32503608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between virological response and FIB-4 index in chronic hepatitis B patients with entecavir therapy.
    Li N; Xu JH; Yu M; Wang S; Si CW; Yu YY
    World J Gastroenterol; 2015 Nov; 21(43):12421-9. PubMed ID: 26604649
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Combined anluohuaxianwan and entecavir treatment significantly improve the improvement rate of liver fibrosis in patients with chronic hepatitis B virus infection].
    Miao L; Yang WN; Dong XQ; Zhang ZQ; Xie SB; Zhang DZ; Zhang XQ; Cheng J; Zhang G; Zhao WF; Xie Q; Liu YX; Ma AL; Li J; Shang J; Bai L; Cao LH; Zou ZQ; Li JB; Lyu FD; Liu H; Wang ZJ; Zhang MX; Chen LM; Liang WF; Gao H; Zhuang H; Zhao H; Wang GQ
    Zhonghua Gan Zang Bing Za Zhi; 2019 Jul; 27(7):521-526. PubMed ID: 31357778
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparative efficacy of tenofovir and entecavir in nucleos(t)ide analogue-naive chronic hepatitis B: A systematic review and meta-analysis.
    Chen MB; Wang H; Zheng QH; Zheng XW; Fan JN; Ding YL; Niu JL
    PLoS One; 2019; 14(11):e0224773. PubMed ID: 31751366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prolonged use of tenofovir and entecavir in hepatitis B virus-related cirrhosis.
    Goyal SK; Dixit VK; Shukla SK; Ghosh J; Behera M; Tripathi M; Gupta N; Ranjan A; Jain AK
    Indian J Gastroenterol; 2015 Jul; 34(4):286-91. PubMed ID: 26243587
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nucleoside analogs assisted with Chinese compound prescription in treating hepatic fibrosis of chronic hepatitis B patients: A protocol of systematic review and meta-analysis.
    Cheng M; Feng X; Wang L; Yang Y; Ma L; Wang B
    Medicine (Baltimore); 2020 Jul; 99(27):e21032. PubMed ID: 32629728
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Meta-analysis of efficacy and safety of Liuwei Wuling Tablets combined with conventional drugs in treatment of liver fibrosis and cirrhosis in chronic hepatitis B].
    Hou MT; Ding KX; He TT; Yang Y; Bai ZF; Xiao XH
    Zhongguo Zhong Yao Za Zhi; 2022 Jan; 47(1):224-234. PubMed ID: 35178929
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of telbivudine compared with entecavir in hepatitis B virus-related cirrhosis: 2 year follow-up data.
    Kim HR; Yim HJ; Kang S; Suh SJ; Kim SY; Hyun JJ; Koo JS; Kim JH; Seo YS; Yeon JE; Lee SW; Byun KS; Um SH
    Liver Int; 2015 Mar; 35(3):860-9. PubMed ID: 24905912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.